Sign in

CIK 0001936258 · Large accelerated filer

NewAmsterdam Pharma Co N.V.

Sign in to watch
Ticker
NAMS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Netherlands
Entity type
operating
Phone
35 206 2971
Business address
GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
Former names
NewAmsterdam Pharma Co B.V.

Securities

  • NAMS Ordinary Shares Nasdaq
  • NAMSW Warrant Nasdaq
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. 4 Planned sale Chief Operating Officer sold 70,441 shares
  3. 4 Planned sale Chief Financial Officer sold 61,883 shares
  4. 4 Planned sale Chief Operating Officer sold 129,559 shares
  5. 144 Insider Sale of Securities
  6. 144 Insider Sale of Securities
  7. 144 Insider Sale of Securities
  8. 8-K Event Regulation FD disclosure
  9. 4 Grant or award Director acquired 6,960 shares (grant or award)
  10. 4 Grant or award Director acquired 6,960 shares (grant or award)
  11. 4 Grant or award Director acquired 6,960 shares (grant or award)
  12. 4 Grant or award Director acquired 6,960 shares (grant or award)
  13. 4 Grant or award Director acquired 6,960 shares (grant or award)
  14. 4 Grant or award Chief Accounting Officer acquired 15,000 shares (grant or award)
  15. 4 Grant or award Chief Executive Officer acquired 123,529 shares (grant or award)
  16. 4 Grant or award Chief Scientific Officer acquired 34,000 shares (grant or award)
  17. 4 Grant or award Chief Business Officer acquired 14,000 shares (grant or award)
  18. 4 Grant or award Chief Commercial Officer acquired 43,000 shares (grant or award)
  19. 4 Grant or award Chief Operating Officer acquired 44,000 shares (grant or award)
  20. 4 Grant or award Chief Financial Officer acquired 38,000 shares (grant or award)

Page 9 of 21 · 415 filings